Coexisting NRAS and BRAF mutations in primary familial melanomas with specific CDKN2A germline alterations.
Jovanovic
Braslav
B
Egyhazi
Suzanne
S
Eskandarpour
Malihe
M
Ghiorzo
Paola
P
Palmer
Jane M
JM
Bianchi Scarrà
Giovanna
G
Hayward
Nicholas K
NK
Hansson
Johan
J
D000328:Adult; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000096:biosynthesis / Q000235:genetics*; D005192:Family Health; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D018095:Germ-Line Mutation; D006801:Humans; D008297:Male; D008545:Melanoma / Q000235:genetics*; D008875:Middle Aged; D009154:Mutation; D048493:Proto-Oncogene Proteins B-raf / Q000096:biosynthesis / Q000235:genetics*; D012878:Skin Neoplasms / Q000235:genetics*; D018631:ras Proteins / Q000096:biosynthesis / Q000235:genetics*
D019941:Cyclin-Dependent Kinase Inhibitor p16; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D018631:ras Proteins